Clinical data shows that patients who maintain a fixed injection schedule report more stable energy levels and fewer breakthrough hunger episodes
However, their price point and potential side effects mean not everyone can access them
Retatrutide: Eli Lillys Triple-Agonist Weight Loss Injection Explained (May 2026 Update) Eli Lillys latest development, Retatrutide , is showing extraordinary potential as a groundbreaking treatment for obesity and metabolic health
Rodbard HW, Rosenstock J, Canani LH, Deerochanawong C, Gumprecht J, Lindberg S, Lingvay I, Sndergaard AL, Treppendahl MB, Montanya E., PIONEER 2 Investigators